[1] |
Majraundar A J, Wong W J,Simon M C. Hypxia-inducible factors and the response to hypoxic stress[J]. Molecular Cell, 2010,40(2):294-309.
|
[2] |
徐 敏,聂时南.低氧诱导因子1在缺氧性疾病中的作用研究[J].临床急诊杂志,2014. 9(15): 564-566.
|
[3] |
Kamoshida G, Ogawa T, Oyanagi J, et al .Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332 (laminin-5)[J]. Clin Exp Metastasis, 2014, 31(3):285-291.
|
[4] |
Watabe Tadashi, Kanai Yasukazu, et al . Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET[J]. EJNMMI Res, 2017, 1(7):16
|
[5] |
刘 瑞,花宝金,侯 炜.从气机升降学说论肿瘤病机[J].中医杂志,2014,55(7):544-547.
|
[6] |
孙宏新,蒋士卿,朴炳奎,等.益肺清化膏对早期非小细胞肺癌术后患者治疗作用的随机对照研究[J].光明中医,2005,20(5):55-57.
|
[7] |
洪 日,吴永强,吴 越.西黄丸辅助治疗中晚期乳腺癌的疗效观察[J].中国中药杂志,2014,39(6):1120-1123.
|
[8] |
周岱翰,林丽珠,田华琴 ,等.益气化痰法为主中医药治疗方案对老年非小细胞肺癌中位生存期的影响:一项多中心、前瞻性临床队列研究[J].世界中医药,2014,7(9):833-837.
|
[9] |
赵红佳,杜 建,陈 曦,等.扶正抑瘤方协同微波消融治疗肝癌的临床研究[J].中国中西医结合杂志,2012,1(32):32-34.
|
[10] |
陶旭辉,唐德才.肿瘤血管生成及中药抗肿瘤血管生成研究进展[J].中药材, 2003,26(5):379-381.
|
[11] |
吕 扬,张 鹏,HIF-1α的研究进展及与肺癌的关系[J].中国肺癌杂志,2009,2(12):147-150.
|
[12] |
Newman A C, Hughes C C. Macrophages and angiogenesis: a role for Wnt signaling[J].Vase Ce11,2012,4(1):13.
|
[13] |
Li D W, Dong P, Wang F, et al . Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1alpha[J].Asian Pac J Cancer Prev, 2013, 14(8):4853-4858.
|
[14] |
Borsi E,Terragna C,Brioli A, et al .Therapeutic targeting of hypoxia and hypoxia inducible factor 1alpha in multiple myeloma[J].Transl Res, 2015, 65(6):641-650.
|
[15] |
Semenza, G L. Defining the role of hypoxia- inducible factor 1 in cancer biology and therapeutics[J]. Oncogene, 2010,2(9): 625-634.
|
[16] |
Catalan V, Gomez-Ambrosi J, Rodriguez A, et al . Up-regulation of the novel roinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer[J].J Nutr Biochem, 2011,22(7):634-641.
|
[17] |
王金良,孔佩艳,徐 葳,等.人参皂苷Rg3 抑制急性白血病骨髓基质细胞HIF21α及VEGF的表达及其机制探讨[J].第三军医大学学报,2010,32(7):621-624.
|
[18] |
陈明伟,倪 磊,赵小革,等.人参皂甙-Rg3对肿瘤血管生成调控因子蛋白表达抑制作用的研究[J].中国中药杂志,2005,30(5):357-360.
|
[19] |
梁丽娟,董婷霞,詹华强,等.黄芪中7种活性成分对缺氧诱导因子(HIF-1)表达的影响[J].中国药房,2010,4(7):4422-4424.
|
[20] |
庄 钦,毛 威.丹参多种活性成分调节血管新生机制的研究概述[J].浙江中医药大学学报,2014,38(4):506-510.
|
[21] |
Rong Fu,Yan Chen. Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis[J].Oncotarget,2015,12(30):1832.
|
[22] |
Song X, Yao J, Wang F, et al .Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein[J].Toxicology and Applied Pharmacology, 2013,271(2): 144-155.
|
[23] |
张金平.红景天苷通过PI3K/Akt激活HIF-1α表达抑制缺氧诱导的心肌细胞凋亡 [D] .第四军医大学,2008.
|
[24] |
孙 军,李 岩.姜黄素对人肝癌细胞BEL-7402中HIF-1α表达的影响[J].中国药理学通报, 2006,1(11): 1379-1383.
|
[25] |
朱凌宇,顾 贤.三七提取物对三硝基苯磺酸诱导溃疡性结肠炎大鼠结肠血管生成的研究[J].中国中西医结合消化杂志,2008,16(2):99-102.
|
[26] |
李厚忠,任公平,张羽飞,等,中药川贝对哮喘模型小鼠VEGF和HIF-1α表达的影响[J].中医药信息,2014,7(31):23-26.
|
[27] |
毛竹君,张慈安,武 峰,等.生半夏、南星水提物对人胃癌BGC823细胞的侵袭力及HIF-1α mRNA蛋白表达的影响[J].现代生物医学进展,2011,10(10):1861-1864.
|
[28] |
刘 丹.白花蛇舌草复方提取物抗癌作用的分子机理研究[D]. 苏州:苏州大学,2009.
|
[29] |
张妮娜.半枝莲含药血清抑制肿瘤血管生成的实验研究[D]. 扬州:扬州大学,2005.
|
[30] |
乔路敏.苏木、鸡血藤及其分别联合顺铂对肺癌细胞增殖、周期的调控作用[D].北京中医药大学,2014.
|
[31] |
臧文华.黄芪-莪术配伍及联合顺铂对人肝癌裸鼠原位移植瘤生长的抑制作用[J].中国实验方剂学杂志,2014,1(5):131-136.
|
[32] |
吴秀丽.散结抗瘤方对S180荷瘤小鼠抑瘤作用和抗血管生成的实验研究 [D] .南方医科大学,2010.
|
[33] |
胡欣欣,李久现,张勤华,等.增免抑瘤方对顺铂耐药卵巢癌裸鼠耐药相关基因HIF-1α、Glut1、MDR1、P-gp表达的影响[J].上海中医药杂志,2012,4(6): 61-64.
|
[34] |
薛 松,钟美佐,刘 巍,等.黄芪扶正汤抗小鼠Lewis肺癌机制的实验研究[J].肿瘤药,2011,2(1)1:37-39.
|
[35] |
高绍芳,王彦刚,李佃贵,等.化浊解毒和胃方对胃癌前病变大鼠血管生成机制的影响[J].中国中西医结合杂志,2013,33(11):1511-1518.
|
[36] |
Yan D Q, Liu Y Q, Li Y D, et al .Tumor inhibition effects and mechanisms of Angelica sinensis and Sophorae flavescentis ait decoction combined with cisplatin in xenograft mice[J].Asian Pac J Cancer Prev,2014,15(11):4609-4615.
|
[37] |
Yu X,Tong Y,Kwok H F, et al .Anti-angiogenic activity of Erxian Decoction,a traditional Chinese herbal formula,in zebrafish[J].Biol Pharm Bull,2012,35(12):2119-2127.
|
[38] |
Yu X 1,Tong Y,Huang W, et al .Erxian decoction,a traditional chinese herbal formula, inhibits angiogenesis in human umbilical vein endothelial cells[J].Biol Pharm Bull,2013,36(5):754-763.
|
[39] |
袁玉梅,史亚飞.胃痞消对胃癌前病变大鼠胃黏膜有氧糖酵解的调控机制[D].广州:广州中医药大学,2014.
|
[40] |
怀其娟,韩凤娟.理冲生随饮对人卯巢癌细胞株SKOV3信号转导基因表达的影响[D].哈尔滨:黑龙江中医药大学,2010.
|
[41] |
贾程辉,李 杰.扶正解毒方对移植性前胃癌小鼠术后复发模型肿瘤相关巨噬细胞的调控作用研究[D].北京:北京中医药大学,2014.
|
[42] |
高连印,韦艾凌.癌痛消对肝细胞癌缺氧微环境细胞因子HIF-lα、VEGF及PHD2的调节作用的研究[D].长沙:湖南中医药大学,2014.
|
[43] |
刘曼曼,余 涛,陈 旻,等.抑癌方对小鼠肠癌移植瘤微血管生成及VEGF、HIF-1a表达的影响[J].辽宁中医药大学学报,2011,6(13):74-76.
|
[44] |
张 铭,董 昀,徐振晔,等.肺岩宁方对A549 裸鼠移植瘤VEGF 与HIF-1α表达的影响[J].上海中医药杂志, 2008,5(42 ):83-85.
|
[45] |
张艳丽,贾永森,秦丽娟,等.通莲汤对裸小鼠胃癌移植瘤生长及缺氧诱导因子HIF-1α的影响[J].吉林中医药,2015,8(35):837-840.
|
[46] |
陈 超,陈慧彬,滕鸣健,等.扶正散结汤拆方对Lewis肺癌移植瘤MVD、HIF-1α及COX-2的影响[J].世界中西医结合,2015,10(4):483-486.
|
[47] |
Lin C C, Huang C Y, Mong M C, et al . Antiangiogenic potential of three triterpenic acids in human liver cancer cells[J].Agric Food Chem,2011,1(59):755-762.
|
[48] |
陈 超,陈慧彬,滕鸣健,等.扶正散结汤拆方对Lewis肺癌移植瘤MVD、HIF-1α及COX-2的影响[J].世界中西医结合,2015,10(4):483-486.
|
[49] |
Zagzag D,Zhong H,Scalzitti J M, et al .Expression of hypoxia inducible factor 1 alpha in brain tumors: association with angiogenesis,invasion,and progression[J].Cancer, 2000,88(2):2606-2618.
|
[50] |
杨 婷,钱亚云. 中药干预肿瘤乏氧微环境的研究[J].时珍国医国药,2017,28(2):434.
|
|
|